Drugs / PG324
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02674854 | Feb 2016 → Mar 2017 | ocular hypertension, open-angle glaucoma | Aerie Pharmaceuticals | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PG324 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02674854 ↗ |